Senior Research Fellow (Executive), The Chinese Medicine Hospital of Hong Kong

THE CHINESE MEDICINE HOSPITAL OF HONG KONG

The Chinese Medicine Hospital of Hong Kong (CMHHK) stands as a flagship Chinese medicine (CM) institution dedicated to advancing Chinese medicine in Hong Kong and is expected to commence operation in phases at the end of 2025. 

Established through a public-private partnership, the hospital is being constructed by the government, with HKBU appointed as the contractor in June 2021 through a tendering process. Subsequently, HKBU registered “HKBU Chinese Medicine Hospital Company Limited” as the operator in accordance with the requirements of the service deed, which is responsible for the management, operation, and maintenance of CMHHK. 

A hallmark of CMHHK is its integrated approach, blending Chinese and Western medicine to provide professional patient care. CMHHK will actively engage in various interactions and collaborate with the industry to promote the development of Chinese medicine across Hong Kong, the Guangdong-Hong Kong-Macao Greater Bay Area, and international institutions. By sharing resources and expertise, CMHHK aims to advance the standardisation and globalisation of Chinese medicine, opening new directions for future healthcare services. 

We warmly invite dedicated individuals to join our team, where you can contribute to the future of Chinese medicine. Together, we can make a meaningful difference in the health and well-being of our community and create a brighter future! 

Senior Research Fellow (Executive) (25260184)

Responsibilities:

• Lead a research administration team as the Central Administrator of the Herb-Drug Interaction International Research Consortium (HDIIRC);
• Oversee, supervise and monitor the implementation and operation of the HDIIRC and Hong Kong platform;
• Devise a systematic administration mechanism for consolidating, evaluating and cross-validating relevant scientific results and findings, and related documents and information contributed by the member organisations of HDIIRC and Hong Kong platform;
• Engage and maintain close liaison with the member organisations of HDIIRC and Hong Kong platform by hosting regular meetings and report the collaboration progress to relevant bodies;
• Set up long-term plan for promoting sustainable development, updating, dissemination and implementation of herb-drug interaction (HDI) clinical practice guideline (CPG) locally and internationally;
• Design and conduct training curricula and workshops on HDI CPG for clinicians and researchers locally and internationally;
• Manage and oversee the HDIIRC initiatives including international meetings, workshops, conferences and seminars to disseminate research findings and engage with global stakeholders;
• Host and organise the inauguration of the HDIIRC and annual conference for HDI;
• Monitor the project progress and the completion of the deliverables amongst member organisations; 
• Prepare and review documentation including meeting papers and reports;
• Cultivate collaborative research and grant proposal application related to HDI amongst member organisations; and 
• Perform any other duties as assigned by the supervisor.

Requirements:

• Applicants should possess a PhD in Toxicology, Epidemiology, Chinese Medicine, Pharmacy in Chinese Medicine, or other background including Pharmacology, Pharmacy, Biostatistics or healthcare-related disciplines;
• Preference will be given to candidates with experience in organising international consortiums and conference; 
• Preference will be given to candidates with solid skills in clinical practice guidelines development, as well as its dissemination and implementation;
• Excellent interpersonal communication and scientific presentation skills are required; 
• Organised, self-motivated and able to work independently as well as in a team; 
• Good command of both written and spoken English and Chinese (Cantonese and Putonghua);
• The initial appointment will be offered on a fixed-term contract of up to two to three years; and
• Rank and salary will be commensurate with qualifications and experience.
• At least 7 years of post-doctoral working experience in research administration, research, teaching and training with relevance in the fields of toxicology, clinical research or clinical practice guidelines development; 

The initial appointment will be offered on a fixed-term contract by Hong Kong Baptist University. Following the commencement of CMH, and subject to the candidate’s satisfactory performance and the decision of CMH, subsequent appointment will be offered directly by CMH.

Shortlisted candidates will be invited to attend a written test. 

Work location: Kowloon Tong Campus and will be moved to The Chinese Medicine Hospital of Hong Kong in Tseung Kwan O when close to commissioning.

Salary will be commensurate with qualifications and experience.

Application Procedure:

Applicants are invited to submit their applications at the HKBU e-Recruitment System. Details of the University’s Personal Information Collection Statement can be found at https://hro.hkbu.edu.hk/en/worklife-at-hkbu/employee-favourable-environment.html#privacy-policy.

The University reserves the right not to make an appointment for the posts advertised, and the appointment will be made according to the terms and conditions applicable at the time of offer.

Review of applications is ongoing until the position is filled.